In silico Toxicity and Pharmaceutical Properties to Get Candidates for Antitumor Drug

Dewa Ayu Made Adnyaswari *

Master's Study Program in Biomedical Sciences, concentration in Basic Medical Sciences, Faculty of Medicine, Udayana University, 80234, Denpasar, Bali, Indonesia.

Agung Wiwiek Indrayani

Department of Pharmacology and Therapy, Faculty of Medicine, Udayana University, 80234, Denpasar, Bali, Indonesia.

I. Gusti Ayu Artini

Department of Pharmacology and Therapy, Faculty of Medicine, Udayana University, 80234, Denpasar, Bali, Indonesia.

*Author to whom correspondence should be addressed.


Abstract

Background: Drug metabolism is a crucial aspect of medical practice and pharmacology, involving the transformation of drugs by various bodily systems to create compounds that are more easily eliminated from the body. Sorafenib was reported as a useful adjuvant treatment in patients with hepatocellular carcinoma who underwent surgical resection. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavailability, restricting its further clinical application. Rosmarinic acid, soluble in ethanol and found in Rosemary leaves, has demonstrated therapeutic benefits in conditions such as cancer, diabetes, inflammatory disorders, neurodegenerative disorders, and liver disease. 

Method: In silico is a term for experiments or tests carried out using computer simulation methods. In silico testing has emerged as a valuable approach for initiating the exploration of novel drug compounds or enhancing the efficacy of existing ones. This method involves predicting, generating hypotheses, and uncovering potential breakthroughs in medicine and therapy through virtual simulations.

Results: Caco2 value of Sorafenib ligand as a comparison, namely 0.762. The highest Caco2 value is owned by Betulinic Acid and the value The lowest Caco2 is owned by Rosmarinic Acid. The highest sample HIA value was owned by Ursolic Acid and the lowest was owned by Rosmarinic Acid. Meanwhile, Sorafenib's HIA value is 85,494. ligands such as Carnosol and rosmanol have a high distribution volume, while the Sama carnosic league, ursolic acid and betulinic acid have a low distribution volume. The Rosmarinic acid ligand has a good distribution volume of 0.393, while the distribution volume value of Sorafenib is -0.009. The highest BBB sample value was owned by Carnosol and the lowest was owned by Rosmarinic acid. Meanwhile, the comparison ligand has a value of -1.473 and is considered less distributed in the brain. all ligands such as Carnosic Acid, Carnosol, Rosmanol, Ursolic Acid, Betulinic Acid, Rosmarinic acid do not have mutagenicity and Cytotoxic effects, but have an effect on immunity. The comparison ligand Sorafenib turned out to have effects on hepatotoxicity, immunity and cytotoxicity.

Conclusion: In pharmacokinetic research, the six phenolic acid compounds in Rosemary exhibited superior properties compared to the reference ligand Sorafenib.

Keywords: Rosemary, rosmarinic acid, insilico, pharmaceutical properties, antitumor


How to Cite

Adnyaswari, D. A. M., Indrayani , A. W. and Artini , I. G. A. (2024) “In silico Toxicity and Pharmaceutical Properties to Get Candidates for Antitumor Drug”, Journal of Pharmaceutical Research International, 36(2), pp. 1–11. doi: 10.9734/jpri/2024/v36i27497.

Downloads

Download data is not yet available.

References

Saad M, Zhang R, Cucchiarini A, Mehawej C, Mergny JL, Mroueh M, et al. G-quadruplex forming sequences in the genes coding for cytochrome P450 enzymes and their potential roles in drug metabolism. Biochimie. 2023;214:45–56 Available:https://doi.org/10.1016/j.biochi.2023.08.014

Susa ST, Hussain A, Preuss C V. Drug Metabolism. In Treasure Island (FL); 2023.

Colizzi M, Weltens N, McGuire P, Van Oudenhove L, Bhattacharyya S. Descriptive psychopathology of the acute effects of intravenous delta-9-tetrahydrocannabinol administration in humans. Brain Sci. 2019;9(4).

Almazroo OA, Miah MK, Venkataramanan R. Drug Metabolism in the Liver. Clin Liver Dis. 2017;21(1):1–20.

Huang S, Li D, Zhuang LL, Sun L, Wu J. A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection. World J Surg Oncol. 2021;19(1):1–11.

Chen F, Fang Y, Chen X, Deng R, Zhang Y, Shao J. Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy. Asian J Pharm Sci. 2021;16(3): 318–36.

Available:https://doi.org/10.1016/j.ajps.2020.07.003

Noor S, Mohammad T, Rub MA, Raza A, Azum N, Yadav DK, et al. Biomedical features and therapeutic potential of rosmarinic acid. Arch Pharm Res. 2022;45 (4):205–28. Available:https://doi.org/10.1007/s12272-022-01378-2

Nursanti O, Aziz A, Hadisoebroto G. Toxicity and Pharmacokinetic Prediction for Analgesic Drug Candidates. J Noncommunicable Dis. 2023;3(1): 34.

Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257–63.

Rizzo A, Ricci AD, Fanizzi A, Massafra R, De Luca R, Brandi G. Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-Analysis. Curr Oncol. 2023;30(1):749– 57.

Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066–72.

Ajani TA, Obikeze K, Magwebu ZE, Egieyeh S, Chauke CG. In ‑ silico and in ‑ vitro screening of Asiatic acid and Asiaticoside A against Cathepsin S enzyme. BMC Pharmacol Toxicol. 2023;1–9. Available:https://doi.org/10.1186/s40360-023-00701-x